首页> 美国卫生研究院文献>Prostate International >Prostate-specific antigen response rate of sequential chemotherapy in castration-resistant prostate cancer: the results of real life practice

【2h】

Prostate-specific antigen response rate of sequential chemotherapy in castration-resistant prostate cancer: the results of real life practice

机译：cast割抗性前列腺癌序贯化疗的前列腺特异性抗原反应率：现实生活中的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose:Prostate-specific antigen (PSA) response rate (>50% PSA decline in pretreatment PSA following chemotherapy) carries a significant survival advantage in castration-resistant prostate cancer (CRPC). We compared PSA response rates in first-, second- and third-line chemotherapy after failure of previous chemotherapy according to chemotherapeutic agents.

机译：目的：前列腺特异性抗原（PSA）响应率（化疗后PSA预处理中PSA下降> 50％）在去势抵抗性前列腺癌（CRPC）中具有显着的生存优势。我们根据化疗药物比较了先前化疗失败后的一线，二线和三线化疗的PSA反应率。

著录项

期刊名称 Prostate International
作者
Geehyun Song; Chunwoo Lee; Dalsan You; In Gab Jeong; Jun Hyuk Hong; Hanjong Ahn; Choung-Soo Kim;
展开▼
作者单位

展开▼
年(卷),期 2013(1),3
年度 2013
页码 125–132
总页数 7
原文格式 PDF
正文语种
中图分类
关键词
Castration refractory prostate cancer Chemotherapy Prostate-specific antigen;

机译：去势难治性前列腺癌;化学疗法;前列腺特异性抗原;

相似文献

外文文献
中文文献
专利

1. Prostate-specific antigen response rate of sequential chemotherapy in castration-resistant prostate cancer: the results of real life practice [J] . Geehyun Song, Chunwoo Lee, Dalsan You, Prostate International . 2013,第3期

机译：cast割抗性前列腺癌序贯化疗的前列腺特异性抗原反应率：现实生活中的结果
2. CLINICAL RESPONSE AND TIME TO PROSTATE-SPECIFIC ANTIGEN (PSA) PROGRESSION IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) RECEIVING SECOND-LINE CHEMOTHERAPY VERSUS ALTERNATIVE ANDROGEN RECEPTOR-TARGETED AGENTS (ARTA) AFTER A LACK OF RESPONSE TO FIRST-LINE ARTA IN US COMMUNITY ONCOLOGY PRACTICES [J] . Oh W. K., Cheng W. Y., Miao R., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2017,第5期

机译：在缺乏对第一线ARTA缺乏反应之后，转移阉割抗性前列腺癌（MCRPC）接受二线化疗的患者前列腺特异性抗原（PSA）进展的临床响应和时间在美国社区肿瘤学实践中
3. The Phase 3 COU-AA-302 Study of Abiraterone Acetate Plus Prednisone in Men with Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer: Stratified Analysis Based on Pain, Prostate-specific Antigen, and Gleason Score [J] . Miller Kurt, Carles Joan, Gschwend Juergen E., European urology . 2018,第1期

机译：第3阶段CO-AA-302研究Abiraaterone醋酸盐加入泼尼松在细胞化疗 - 幼稚转移性阉割前列腺癌中的研究：基于疼痛，前列腺特异性抗原和Gleason评分的分层分析
4. Analysis of glycoforms of urinary prostate-specific antigen of prostate cancer and benign prostate hyperplasia samples [C] . Chun-Jen Hsiao, Tzong-Shin Tzai, Chein-Hung Chen, ASMS Conference on Mass Spectrometry and Allied Topics . 2015

机译：前列腺癌和良性前列腺增生样品的尿道前列腺特异性抗原糖族分析
5. Studies on human prostate-specific antigen as a tumor antigen for the immunotherapy of prostate cancer in a mouse model. [D] . Willis, Richard Allen. 2002

机译：人类前列腺特异性抗原作为一种肿瘤抗原的免疫模型在小鼠模型中的研究。
6. Comparison of prostate cancer detection rates of various prostate biopsy methods for patients with prostate-specific antigen levels of 10.0 ng/mL in real-world practice [O] . Kyung Tak Oh, Kyo Chul Koo, Byung Ha Chung, 2020

机译：在现实世界中前列腺特异性抗原水平10.0 ng / mL的患者各种前列腺活检方法的前列腺癌检出率比较
7. Prostate-specific antigen response rate of sequential chemotherapy in castration-resistant prostate cancer: the results of real life practice [O] . Song Geehyun, Lee Chunwoo, You Dalsan, 2013

机译：cast割抗性前列腺癌序贯化疗的前列腺特异性抗原反应率：现实生活中的结果
8. Characterization of Prostate-Specific Membrane Antigen (PSMA) for Use in Therapeutic and Diagnostic Strategies Against Prostate Cancer [R] . O'Keefe, D. S. , Heston, W. D. 2002

机译：表征前列腺特异性膜抗原（psma）用于治疗和诊断前列腺癌的策略

Prostate-specific antigen response rate of sequential chemotherapy in castration-resistant prostate cancer: the results of real life practice

摘要

著录项

相似文献

相关主题

期刊订阅